logo
Plus   Neg
Share
Email

Meredith Slips To Loss In Q3; Results Miss View

Meredith Corp. (MDP) reported that its third-quarter net loss was $284.4 million or $6.65 per share compared to net income of $23.7 million or $0.10 per share in the prior year.

Loss from continuing operations was $289 million in the third quarter of fiscal 2020. The loss was due primarily to non-cash impairments of goodwill and intangible assets of $296 million as well as lease-related assets exited as part of ongoing synergy activities of $88 million.

Earnings from continuing operations before special items were $0.49 compared to $0.52 last year. Analysts polled by Thomson Reuters expected the company to report earnings of $1.10 per share for the quarter. Analysts' estimates typically exclude special items.

Adjusted EBITDA was $152 million, compared to $161 million in the prior year, hurt primarily by COVID-19-related declines in advertising, partially offset by increased political advertising.

Quarterly revenues were $702 million, a decline of 6 percent from the prior year period, due primarily to previously announced magazine portfolio adjustments to improve profitability that reduced advertising and consumer related revenues by a total of $40 million and COVID-19 related advertising cancellations and delays that reduced revenues by $17 million. The changes were partially offset by $10 million of incremental broadcasting political advertising revenues compared to the prior year period. Analysts expected revenues of $720.83 million for the third-quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Volkswagen Group were gaining around 3 percent in German trading after the automotive giant Thursday reported market recovery in the third quarter with improved deliveries in the month of September. For the first nine months of fiscal 2020, the company, meanwhile reported sharply lower earnings with weak revenues and sales volume. Comcast Corp. on Thursday reported a 37 percent decline in profit for the third quarter from last year, hurt primarily by revenue decline at NBCUniversal. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend. In the pre-market trade, CMCSA is trading at $42.83, up $0.85 or 2.02 percent. Regeneron announced positive results from its late stage COVID-19 outpatient trial, indicating that its antibody cocktail therapy significantly reduced virus levels and need for further medical attention. The trial results showed that investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.
RELATED NEWS
Follow RTT